Earth Science Tech: Healthcare Growth Meets Aggressive Share Buybacks

Earth Science Tech (OTC: ETST) has transformed into a diversified healthcare holding company, operating across telemedicine, compounding pharmacies, clinical support services, and healthcare fulfillment. The company is making headlines not only for its expanding healthcare platform but also for its aggressive share repurchase program, which has significantly reduced its outstanding share count. According to its most recent Form 10-Q for the quarter ended December 31, 2025, Earth Science Tech repurchased 1,143,000 common shares during the quarter, part of a broader buyback of 3.7 million shares over the nine-month period, spending approximately $647,000. This dual strategy of operational growth and balance-sheet management underscores management's commitment to enhancing shareholder value.

For investors evaluating OTC-listed companies, share structure often weighs as heavily as revenue growth or acquisition activity. Earth Science Tech's sustained repurchase program has distinguished it among peers, reducing outstanding shares while the company continues to expand its healthcare-focused platform. The company's recent 10-Q filing provides detailed insights into the pace of these repurchases, accessible via the provided link. Management emphasizes that shareholder value remains a priority, achieved through both acquisitions and careful balance-sheet management. The company is scheduled to present at the Planet MicroCap Las Vegas 2026 conference in June, offering further visibility into its strategy.

Earth Science Tech's approach reflects a broader trend among micro-cap companies seeking to boost shareholder returns through buybacks while pursuing growth. By repurchasing shares at a pace that steadily reduces the float, the company aims to create a more attractive investment profile. The company's newsroom, available at https://ibn.fm/ETST, provides ongoing updates. As Earth Science Tech continues to pair its healthcare expansion with financial discipline, it presents a unique case study in how micro-cap firms can leverage both operational and capital allocation strategies to drive long-term value.